Trials / Completed
CompletedNCT03700346
Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients
Muscle Lactate and Lactate to Pyruvate Ratio Clearance as Useful Biomarkers for the Prediction of Mortality in Septic Shock Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Military Hospital of Tunis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We conducted this study aiming to assess the performance of muscle Lactate and lactate to pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using microdialysis.
Detailed description
Microcirculatory alterations are frequently observed in patients with sepsis. In vivo microdialysis (MD) is a bedside technique that can monitor tissue metabolic changes. We conducted this study aiming to assess the performance of muscle Lactate and lactate to pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using microdialysis. Interstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained at baseline and every 6 hours for 3 days by using muscle microdialysis. Clearances of muscle lactate, and L/P ratio were defined as the percentage change in muscle lactate level or L/P ratio compared to baseline (H0) values. A positive value of clearance means a decrease in the rate of the parameter under study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | microdialysis | Interstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained by using muscle microdialysis |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-10-30
- Completion
- 2018-12-31
- First posted
- 2018-10-09
- Last updated
- 2021-04-20
Locations
2 sites across 1 country: Tunisia
Source: ClinicalTrials.gov record NCT03700346. Inclusion in this directory is not an endorsement.